[Genomic abnormalities in myeloproliferative neoplasms].

Abstract excerpt

Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are driven by recurrent driver mutations and evolve through the stepwise accumulation of additional genetic alterations and clonal evolution. Some large cohort studies have demonstrated that individual additional mutations significantly influence prognosis, leukemic transformation, and progression to myelofibrosis. Furthermore, certain mutations...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics
• Share to Mutation
• Share to Myeloproliferative Disorders